Related Experiment Video
Updated: Jun 14, 2026

Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
Published on: March 18, 2011
Rapamycin extends maximal lifespan in cancer-prone mice
Vladimir N Anisimov1, Mark A Zabezhinski, Irina G Popovich
1Department of Carcinogenesis and Oncogerontology, N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia. aging@mail.ru
Abstract:
Aging is associated with obesity and cancer. Calorie restriction both slows down aging and delays cancer. Evidence has emerged that the nutrient-sensing mammalian target of rapamycin (mTOR) pathway is involved in cellular and organismal aging. Here we show that the mTOR inhibitor rapamycin prevents age-related weight gain, decreases rate of aging, increases lifespan, and suppresses carcinogenesis in transgenic HER-2/neu cancer-prone mice. Rapamycin dramatically delayed tumor onset as well as decreased the number of tumors per animal and tumor size. We suggest that, by slowing down organismal aging, rapamycin delays cancer.
Related Concept Videos
Replicative Cell Senescence
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
PI3K/mTOR/AKT Signaling Pathway

